Dr Lamia Kandil
Lamia is a PhD holder lecturer. She obtained her PhD in Biotechnology in 2015. She is also a fellow of Higher Education in the UK. She has experience in teaching in Pharmacy school Overseas from 2008 to 2020. She previously worked as a lecturer in Biomedical sciences at the University of East Anglia until 2022.
Lamia has published studies in the field of Biochemistry, Molecular Biology, Pharmacology and Pharmacogenomics.
In 2022, Lamia held the title of Fellow of Higher Education in the UK. During 2022, she assumed the role of Associate Professor of Biochemistry at Pharos University in Alexandria. From 2021 to 2022, Lamia worked as a Lecturer of Biochemistry and Cell Biology at the School of Biological Sciences, Faculty of Science, University of East Anglia, UK.
Between 2015 and 2020, she served as a Lecturer of Cell and Molecular Biology, Molecular Therapeutics, and Clinical Biochemistry in the Department of Pharmacology and Therapeutics at the Faculty of Pharmacy, Pharos University. During this period, Lamia also oversaw research projects and provided guidance to PhD and Master's degree students.
From 2012 to 2015, she held the position of Assistant Lecturer of Biochemistry, Cell and Molecular Biology within the Department of Pharmacology and Therapeutics at the Faculty of Pharmacy, Pharos University. Between 2008 and 2012, Lamia worked as a Teaching Assistant at the Department of Pharmacology and Toxicology at the Faculty of Pharmacy, Pharos University. From 2007 to 2008, she worked as a Medical Representative at Sanofi Aventis Pharmaceutical Company.
Lamia is motivated, dedicated, and capable of working independently with general guidance. She excels at building and maintaining effective relationships with students and colleagues. Her communication and presentation skills are excellent. She easily adapts to diverse and evolving work environments and comprehends the importance of being a valuable team member.
Initially trained as a biochemist, Lamia's research interests expanded to encompass methodologies involving Cellular Genetics, Biological Chemistry, Pharmacology, Toxicology, and Molecular Biology.
- Alexandria University, BSc in Pharmaceutical sciences, Excellent, 2007
- Alexandria University, Master's degree in Biotechnology, Excellent, 2012
- Alexandria University, PhD degree in Biotechnology, Excellent, 2015
- Teaching Pharmacy students Mpharm
- Fellow of Higher Education, UK
- Member of Biochemical Society, UK
Lamia's research interests have expanded to encompass methodologies that involve Cellular Genetics, Biological Chemistry, Pharmacology, Toxicology, and Molecular Biology. Her areas of expertise include understanding the relationship of genetic instabilities to human diseases and various types of cancer. Additionally, she specialises in studying the effectiveness of new drug formulations for treating Neurodegenerative diseases such as Alzheimer's disease and Rheumatoid arthritis.
- Sherihan Salaheldin Abdelhamid Ibrahim, Lamia Said Kandil, Ghada M. Ragab, Shorouk M. El-Sayyad. Micro RNAs 26b, 20a inversely correlate with GSK-3 β/NF-κB/NLRP-3 pathway to highlight the additive promising effects of atorvastatin and quercetin in experimental induced arthritis, International Immunopharmacology.
- Shorouk M. El-Sayyad, Mennatallah A. Ali, Lamia S. kandil, Ghada M. Ragab, Sherihan S. Abdelhamid Ibrahim. Metformin and omega-3 fish oil elicit anti-inflammatory effects via modulation of some dysregulated micro RNAs expression and signaling pathways in experimental induced arthritis,International Immunopharmacology.
- Noha S. El-Salamouni, Mai M. Ali, Sherien A. Abdelhady, Lamia S. Kandil, Gihan A. Elbatouti & Ragwa M. Farid (2020) Evaluation of chamomile oil and nanoemulgels as a promising treatment option for atopic dermatitis induced in rats, Expert Opinion on Drug Delivery.
- Lamia Said Kandil, Amira Sayed Hanafy & Sherien A. Abdelhady (2020). Galantamine transdermal patch shows higher tolerability over oral galantamine in rheumatoid arthritis rat model, Drug Development and Industrial Pharmacy.
- Bedewy, A.M.L., Showeta, S., Mostafa, M.H. et al. The Influence of CYP2C9 and VKORC1 Gene Polymorphisms on the Response to Warfarin in Egyptians.
Use the links below to view their profiles:
Use the links below to view their profiles: